U.S. Packaging Stock News

NYSE:LTC
NYSE:LTCHealth Care REITs

Is It Time To Reassess LTC Properties (LTC) After Recent Share Price Volatility?

If you are wondering whether LTC Properties at around US$37.39 is offering good value today, the key is understanding what the current price actually implies about the business. The stock has seen a 7.9% return year to date, with a 12.1% return over the past year, a 35.8% return over three years and a 21.3% return over five years, but it also experienced a 5.6% decline over the last week and a 1.9% return over the past month. Recent attention on healthcare real estate investment trusts,...
NasdaqGS:QS
NasdaqGS:QSAuto Components

Is QuantumScape (QS) Now Attractive After An 83.7% One Year Share Price Jump?

Wondering whether QuantumScape at US$7.31 is starting to look attractively priced or still carries a premium? This article breaks down what current market pricing might be implying about the stock. The share price return over the last year sits at 83.7%, with a 2.0% move over the past week, 3.7% over the last month, a 33.9% decline year to date, and a 0.7% return over three years, while the five year return stands at an 80.7% decline. Recent headlines around QuantumScape have kept attention...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Evolv Expands AI Security At Washington Venues As Recurring Revenue Grows

Evolv Technologies Holdings (NasdaqCM:EVLV) is partnering with the University of Washington to install its AI-based security screening systems at major athletic facilities. The company is becoming the Official Fan Screening Partner for these venues, extending its presence in large collegiate sports settings. Evolv focuses on AI-driven physical security, aiming to help venues manage high volumes of visitors while maintaining security screening. By working with a major university athletics...
NYSE:NP
NYSE:NPInsurance

Neptune Buyback Plan Meets Record Growth But Valuation Looks Stretched

Neptune Insurance Holdings (NYSE:NP) reported record new business sales and higher adjusted net income in its latest quarterly update. The company announced a new stock repurchase program to return capital to shareholders alongside these results. Management linked the repurchase plan with recent operating trends and offered investors an updated view of Neptune’s priorities. For investors watching Neptune Insurance Holdings, the combination of fresh financial results and capital return plans...
NYSE:PPL
NYSE:PPLElectric Utilities

Is PPL (PPL) Stock Price Justified After Recent Multi Year Rally?

Wondering if PPL at around US$37.78 is giving you value or just price noise? This article walks through what that price tag might really mean for you. The stock has seen a 4.0% decline over the last 7 days, while returns sit at 2.4% over 30 days, 7.6% year to date and 7.6% over 1 year, with longer term returns of 47.6% over 3 years and 56.8% over 5 years, which shows how the story has evolved over time. Recent coverage of PPL has focused on its role in the US utilities sector and how...
NYSE:MTH
NYSE:MTHConsumer Durables

Meritage Homes Faces Q1 Earnings Pressure While Supporting Shareholders And Growth

Meritage Homes (NYSE:MTH) reported a significant year over year decline in Q1 2026 revenue and net earnings. Management cited a severe winter storm and geopolitical tensions affecting consumer sentiment and mortgage rates as key pressures. The company maintained a strong balance sheet while completing share repurchases and paying dividends during the quarter. Meritage Homes also expanded its community count despite the operational headwinds in Q1 2026. Meritage Homes, a major US...
NasdaqGM:BCBP
NasdaqGM:BCBPBanks

BCB Bancorp (BCBP) Q1 Profit Of US$4.4 Million Tests Bearish Unprofitability Narrative

BCB Bancorp (BCBP) opened 2026 with Q1 total revenue of US$22.2 million and basic EPS of US$0.26, against a trailing twelve month picture that includes total revenue of US$78.8 million and a small net income loss of US$1.2 million. Over recent quarters the company has seen quarterly revenue move between US$2.9 million and US$22.4 million and basic EPS range from a loss of US$0.73 to a profit of US$0.26, so investors are getting a mixed profit story even as the latest quarter lands in positive...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Is It Too Late To Consider Afya (AFYA) After Mixed Returns And DCF Upside?

Wondering whether Afya's current share price around US$15.65 still offers value or if the best entry points are behind you? This review focuses squarely on what the numbers say about the stock. Afya's share price performance is mixed, with returns of 1.0% over 7 days, 3.2% over 30 days and 4.7% year to date, while the 1 year return sits at a loss of 11.2% and the 5 year return at a loss of 31.0%, set against a 3 year gain of 40.8%. Recent news coverage around Afya has centered on its...
NYSE:LEG
NYSE:LEGConsumer Durables

Is Leggett & Platt (LEG) Pricing In Too Much Bad News After Somnigroup Offer Collapse

If you are trying to figure out whether Leggett & Platt at around US$11.40 is a bargain or a value trap, the starting point is understanding what the current share price implies about the business. The stock has recently shown mixed momentum, with returns of 0.4% over 7 days, 13.7% over 30 days, 3.7% year to date, 59.0% over 1 year, and longer term declines of 58.9% over 3 years and 72.6% over 5 years. These moves sit against a backdrop of ongoing attention on the Consumer Durables space and...
NYSE:HHH
NYSE:HHHReal Estate

Howard Hughes Deepens Insurance Pivot With Grandisson Appointment And Warrants

Howard Hughes Holdings (NYSE:HHH) has appointed former Arch Capital CEO Marc Grandisson to its board. The move coincides with the closing of the acquisition of Vantage Group Holdings, expanding the company into insurance and reinsurance. In connection with these changes, HHH issued equity warrants through a private placement that includes participation from Grandisson. Howard Hughes Holdings, trading at $64.72, is in the middle of a significant transition as it adds Marc Grandisson to its...
OTCPK:TRCY
OTCPK:TRCYBanks

Tri City Bankshares (OTCPK:TRCY) Margin Expansion Challenges Longer Term Earnings Decline Narrative

Tri City Bankshares (TRCY) has opened 2026 with Q1 revenue of about US$20.0 million, basic EPS of US$0.43 and net income of roughly US$3.8 million, setting the tone for how investors assess the latest update against recent momentum. Over the past year, the company has seen trailing twelve month revenue move from US$65.9 million to US$79.1 million and basic EPS rise from US$1.32 to US$1.70, alongside trailing earnings growth of 24.8% and a net profit margin of 19.1% compared with 16.9% a year...
NasdaqGS:PFBC
NasdaqGS:PFBCBanks

Preferred Bank (PFBC) Q1 EPS Holds Firm Challenging Cautious Growth Narratives

Preferred Bank (PFBC) has opened 2026 with Q1 revenue of US$68.1 million and basic EPS of US$2.57, setting the tone for investors focused on how current earnings stack up against recent history. Over recent quarters, revenue has moved within a tight band from US$65.9 million in Q1 2025 to US$73.8 million in Q4 2025, while quarterly EPS has ranged between US$2.27 and US$2.90 across the same period, keeping attention firmly on how well the bank is holding its margins. See our full analysis for...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker Bets On Diagnostics And NMR To Reinforce Growth Story

Bruker (NasdaqGS:BRKR) announced new products in microbiology, infection diagnostics and NMR technology, alongside the European launch of a fully automated molecular diagnostics system. The company is expanding its MALDI Biotyper and MyGenius PRO platforms and progressing the integration of Molzym and its pathogen diagnostics portfolio. For investors tracking Bruker, the news arrives with the shares at $39.67. The stock shows mixed performance, with a 13.8% return over the past 30 days and...
NYSE:WAB
NYSE:WABMachinery

Wabtec (WAB) Q1 EPS Growth Tests Bullish Long Term Earnings Narrative

Westinghouse Air Brake Technologies (WAB) opened 2026 with Q1 revenue of US$2.95b and basic EPS of US$2.13, setting the tone for how the year is starting to shape up after a period of steady earnings expansion. The company has seen revenue move from US$2.61b in Q1 2025 to US$2.95b in Q1 2026, while basic EPS over that span ranged from US$1.88 in Q1 2025 to US$2.13 in the latest quarter. Trailing twelve month EPS reached US$7.08 as net income for that period came in at US$1.21b. With earnings...
NYSE:GEV
NYSE:GEVElectrical

GE Vernova (GEV) Net Margin Surge Reinforces Bullish Profitability Narratives

GE Vernova (GEV) has opened 2026 with Q1 total revenue of US$9.3 billion and basic EPS of US$17.64 on net income of US$4.7 billion, setting a clear marker for its latest earnings season update. The company has seen quarterly revenue move from US$8.0 billion in Q1 2025 to US$9.3 billion in Q1 2026, while basic EPS stepped up from US$0.92 to US$17.64 over the same period, alongside trailing 12 month EPS of US$34.66 and net income of US$9.4 billion. With revenue growth forecasts above the wider...
NasdaqGS:IQ
NasdaqGS:IQEntertainment

Is It Time To Reconsider iQIYI (IQ) After Its US$100m Share Repurchase Plan?

With iQIYI trading at US$1.25, many investors are asking whether the current price reflects the underlying value of the business or if the market is being too harsh. Over the last week, the share price return was 11.3% lower, while the 1 year return was 33.2% lower and the 5 year return was 91.9% lower. Together, these figures can change how the market views both risk and potential reward. Recent coverage around iQIYI has focused on how investors interpret these longer term share price moves,...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Old National Bancorp (ONB) EPS Print Reinforces Bullish Earnings Growth Narrative

Old National Bancorp (ONB) opened 2026 with Q1 revenue of US$652.9 million and basic EPS of US$0.60, while trailing 12 month revenue and EPS came in at US$2.5 billion and US$1.95 respectively as the bank continued to convert its top line into earnings. Over recent quarters, revenue has ranged from US$446.6 million in Q1 2025 to US$671.3 million in Q3 2025, with basic EPS moving between US$0.34 and US$0.60 across the same period. This gives investors a clear read on how earnings track...
NYSE:EDU
NYSE:EDUConsumer Services

New Oriental Education NYSE EDU Q3 Net Margin Compression Tests Bullish Efficiency Narrative

New Oriental Education & Technology Group (EDU) has reported a busy Q3 2026, with revenue of US$1.4b and basic EPS of US$0.80, as investors weigh these quarterly figures against a trailing twelve month EPS of US$2.65 on revenue of US$5.4b. Over recent quarters the company has seen revenue move from US$1.0b in Q2 2025 to US$1.4b in Q3 2026, while basic EPS has ranged from US$0.20 to US$1.52 across that stretch. This release is another checkpoint on how consistently the company can convert its...
NasdaqCM:CAAS
NasdaqCM:CAASAuto Components

China Automotive Systems (NasdaqCM:CAAS) Q4 EPS Beat Challenges Margin‑Focused Bear Narratives

China Automotive Systems FY 2025 Earnings Snapshot China Automotive Systems (NasdaqCM:CAAS) has wrapped up FY 2025 with fourth quarter revenue of US$229.2 million and basic EPS of US$0.61, capping a year where trailing twelve month revenue reached US$765.7 million and EPS came in at US$1.42, alongside earnings growth of 5.3% over the past year. The company has seen revenue move from US$188.7 million and EPS of US$0.30 in Q4 2024 to US$229.2 million and EPS of US$0.61 in Q4 2025. Meanwhile,...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Manhattan Associates (MANH) Q1 Margin Cooldown Tests Bullish Expansion Narrative

Manhattan Associates (MANH) opened 2026 with Q1 revenue of US$282.2 million and basic EPS of US$0.83, setting the tone for how its profit engine is carrying into the new year. Over recent quarters the company has seen revenue move from US$262.8 million in Q1 2025 to US$270.4 million in Q4 2025 and now US$282.2 million, while basic EPS has ranged from US$0.86 to US$0.97 over that period and sits at US$0.83 this quarter, putting the focus squarely on how efficiently that top line is being...
NasdaqGS:OZK
NasdaqGS:OZKBanks

Bank OZK Grant Backs Austin Housing While Shares Trade Below Targets

Bank OZK (NasdaqGS:OZK) provided a $2 million grant to support an affordable housing initiative in Austin, Texas. The funding helped facilitate the opening of a 100 unit community in partnership with the Federal Home Loan Bank of Dallas. For anyone following regional banks, this move gives you another data point on how Bank OZK approaches its business beyond core lending and deposit gathering. Affordable housing is a major policy focus in many U.S. cities, and Austin is one of the markets...
NYSE:ENS
NYSE:ENSElectrical

Is It Too Late To Consider EnerSys (ENS) After Its 145% One Year Surge?

Wondering if EnerSys, at a last close of US$202.10, is still reasonably priced after a strong run, or if you are arriving late to the story. The stock has posted returns of 4.2% over 7 days, 18.0% over 30 days, 34.1% year to date, 144.8% over 1 year, 159.0% over 3 years and 127.5% over 5 years, which raises questions about how much future upside or downside is now priced in. Recent coverage has focused on EnerSys as a battery and energy storage supplier tied to long term electrification and...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Tradeweb’s ETF Data Role Grows As Xtrackers Expands iNAV Adoption

Xtrackers has adopted Tradeweb's iNAVs for its Europe listed ETFs, expanding Tradeweb's role in real time ETF valuation. With this move, Tradeweb now supplies independent iNAVs for over half of the assets under management in European listed ETFs. The development further embeds Tradeweb Markets (NasdaqGS:TW) in the core data infrastructure of the European ETF market. Tradeweb Markets, best known for its electronic trading platforms across fixed income, ETFs and derivatives, is steadily...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Is It Too Late To Consider Halozyme Therapeutics (HALO) After Its Recent Share Price Rebound

Investors may be wondering whether Halozyme Therapeutics, at around US$68 per share, still offers value or if most of the upside is already priced in. The stock has a recent 7 day return of 1.6%, a 30 day return of 7.9%, a year to date return of a 2.7% decline, a 1 year return of 17.5%, and a 3 year return a little above a 2x multiple. This naturally raises questions about how current expectations line up with fundamentals. Recent news flow around Halozyme Therapeutics has focused on its...